Showing results (951-960 of 981) with videos related to

Sort By:
Pageof 99
The Journal of Cell Biology|April 6, 2026
Localized active transport shapes the nanoscopic features at the tip of mechanosensory ciliaShan Wang, Yue-Ting Hu, Yan-Rong Chen, et al.
Biomolecules & Biomedicine|May 15, 2023
CSRP2 transcript levels after consolidation therapy increase prognostic prediction ability in B-cell acute lymphoblastic leukaemiaLei-Ming Cao, Ya-Lan Zhou, Robert Peter Gale, et al.
Cell Death and Differentiation|June 3, 2026
Cell death-induced release of the pro-aging protein acyl CoA binding protein (ACBP) into the circulationYan Rong, Flavia Lambertucci, Yaning Yang, et al.
Iscience|November 13, 2019
Targeted Drug-Loaded Chemical Probe Staining Assay to Predict Therapy Response and Function as an Independent Pathological MarkerHeng Zhang, Wei-Long Zhong, Bo Sun, et al.
British Journal of Haematology|February 19, 2020
DPEP1 expression promotes proliferation and survival of leukaemia cells and correlates with relapse in adults with common B cell acute lymphoblastic leukaemiaJia-Min Zhang, Yan Xu, Robert P Gale, et al.
Signal Transduction and Targeted Therapy|October 12, 2025
First-line treatment with chemotherapy, surufatinib (an angio-immuno kinase inhibitor), and camrelizumab (an anti-PD-1 antibody) for locally advanced or metastatic pancreatic ductal adenocarcinoma: a phase Ib/II randomized studyRu Jia, Hai-Yan Si, Meng-Jiao Fan, et al.
Cytometry. Part B, Clinical Cytometry|August 20, 2019
The Quantification of Minimal Residual Disease Pre- and Post-Unmanipulated Haploidentical Allograft by Multiparameter Flow Cytometry in Pediatric Acute Lymphoblastic LeukemiaXin-Yu Wang, Qiao-Zhen Fan, Lan-Ping Xu, et al.
Chinese Medical Journal|December 5, 2018
Association of Persistent Minimal Residual Disease with Poor Outcomes of Patients with Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Stem Cell TransplantationJing Liu, Xiao-Su Zhao, Yan-Rong Liu, et al.
American Journal of Hematology|January 26, 2019
Minimal residual disease status determined by multiparametric flow cytometry pretransplantation predicts the outcome of patients with ALL receiving unmanipulated haploidentical allograftsXiao-Su Zhao, Yan-Rong Liu, Lan-Ping Xu, et al.
Frontiers in Oncology|April 8, 2020
Different Effects of Pre-transplantation Measurable Residual Disease on Outcomes According to Transplant Modality in Patients With Philadelphia Chromosome Positive ALLSi-Qi Li, Qiao-Zhen Fan, Lan-Ping Xu, et al.
Pageof 99